Low Level Laser Therapy for Traumatic Brain Injury
Abstract:
Traumatic Brain Injury or TBIs are common across both military and civilian populations. In the US, the CDC reports an annual TBI incidence of 1.7 million, with 580,000 TBI-associated deaths in the decade 1997-2007. Low-level laser therapy LLLT is unique among the many therapies tested clinically for TBI. Its mechanism of action is biostimulation by near-infraredNIR light. In the proposed work, through both clinical and preclinical investigations, we plan to further investigate the safety and utility of LLLT for acute TBI.
Security Markings
DOCUMENT & CONTEXTUAL SUMMARY
Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release;
RECORD
Collection: TR